Tests and monitoring in HIV infection - PowerPoint PPT Presentation

About This Presentation
Title:

Tests and monitoring in HIV infection

Description:

Tests and monitoring in HIV infection UK standard of care and some other useful tests Matthew Williams UK CAB Tests and monitoring in HIV infection UK standard of ... – PowerPoint PPT presentation

Number of Views:147
Avg rating:3.0/5.0
Slides: 76
Provided by: ukcabNetw
Category:

less

Transcript and Presenter's Notes

Title: Tests and monitoring in HIV infection


1
Tests and monitoring in HIV infection
  • UK standard of care and some other useful tests
  • Matthew Williams
  • UK CAB

2
Tests and monitoring in HIV infection
  • UK standard of care and some other useful tests

3
Tests and monitoring in HIV infection
  • CD4 count
  • Viral load
  • Resistance
  • Therapeutic drug monitoring

4
Tests and monitoring in HIV infection
  • CD4 count
  • Blood test
  • Used to judge how far HIV disease has advanced
  • Helps predict the risk of opportunistic
    infections
  • Most useful when it is compared with the count
    obtained from an earlier test.

5
Tests and monitoring in HIV infection
  • CD4 count
  • CD4 dips on HIV infection from a normal count of
    500-1,500 cells in a cubic millimeter (mm3) of
    blood (a drop, more or less), recovers somewhat,
    then falls over time down to as low as 0.

6
Tests and monitoring in HIV infection
  • CD4 count
  • CD4 lt200 greater risk of opportunistic
    infections (OIs) AIDS threshold for
    prophylaxis eg for PCP bottom of UK threshold
    for starting combination therapy
  • CD4 lt50 very great risk of OIs

7
Tests and monitoring in HIV infection
  • CD4 count
  • CD4 over 350 treatment not recommended
  • CD4 any count treatment recommended if
    symptomatic
  • BHIVA, Treatment of HIV-infected adults with
    antiretroviral therapy (2006)

8
Tests and monitoring in HIV infection
  • CD4 count
  • CD4 count lower in pregnancy temporary drop of
    50 cells/mm3

9
Tests and monitoring in HIV infection
  • CD4 count
  • CD4 - CD4 cells as proportion of all lymphocytes
    (white blood cells), normally about 40 in adults
  • CD4 is used to monitor babies and children who
    have higher CD4 counts

10
Tests and monitoring in HIV infection
  • Viral load
  • Blood test (can be other serum eg CSF)
  • Used to judge whether treatment is working (early
    infection?)
  • Helps predict the risk of disease progression?
  • Most useful when it is compared with the count
    obtained from an earlier test.

11
Tests and monitoring in HIV infection
  • Viral load
  • After infection, viral load surges to a very high
    for the first weeks or months
  • Often 1,000,000 copies in a millilitre (mL) of
    blood, when you are very infectious
  • Viral load falls as the body controls HIV
    infection then rises over time as immunity is
    damaged

12
Tests and monitoring in HIV infection
  • Viral load
  • When you are on HIV treatment, your viral load
    should be reduced to undetectable lt50
    copies/mL 1.7 log10

13
Tests and monitoring in HIV infection
  • Viral load
  • Blip 1 viral load test detectable (over 50
    copies) 2 of these may be a trend and indicate
    virological failure

14
Tests and monitoring in HIV infection
  • Viral load
  • Viral load is usually a PCR (polymerase chain
    reaction) quantitative (counting) test for HIV
    RNA - research tests can measure viral load below
    50 copies
  • Other tests bDNA (branched DNA), NASBA (nucleic
    acid sequence based amplification)

15
Tests and monitoring in HIV infection
  • Resistance test
  • Blood test (can be other serum eg CSF)
  • Used to judge whether treatment will work
  • Involves interpretation
  • Two types genotype and phenotype
  • Viral load needs to be over 500 copies/mL for the
    test to work

16
Tests and monitoring in HIV infection
  • Resistance test

Resistance test
17
Tests and monitoring in HIV infection
  • Resistance test
  • Genotype looks at genetic make up of HIV viruses
    in infection and compares this to what is known
    about which mutations lead to resistance
  • Phenotype looks at whether the drugs work in a
    test tube

18
Tests and monitoring in HIV infection
  • Resistance test
  • Minority species of resistant virus may be missed
    by conventional resistance testing (ie if less
    than 10 of your virus is resistant the test may
    not pick this up).
  • In patients without evidence of transmitted
    resistance, a suboptimal virological response to
    first-line therapy (lt1 log10 copies/mL drop in
    viral load by 48 weeks) should prompt resistance
    testing at that time.
  • BHIVA, Treatment of HIV-infected adults with
    antiretroviral therapy (2006)

19
Tests and monitoring in HIV infection
  • Resistance test

20
Tests and monitoring in HIV infection
  • Therapeutic drug monitoring (TDM)
  • Measures drug levels in the blood - requires
    blood samples at recorded time intervals after a
    drug dose
  • Practical uses for NNRTIs and PIs

21
Tests and monitoring in HIV infection
  • Therapeutic drug monitoring (TDM)
  • Freely available at low (45/drug) or no cost (if
    covered by drug company) from University of
    Liverpool Department of Pharmacology.
  • http//www.hiv-druginteractions.org/
  • http//www.delphicdiagnostics.com/

22
Tests and monitoring in HIV infection
  • Therapeutic drug monitoring (TDM)
  • Drug levels vary much evidence of this
    recommended dose is based on averages
  • University of Liverpool TDM audit 20-25 of
    children on NNRTIs or PIs using drugs below
    therapeutic level.
  • http//www.i-base.info/htb/v7/htb7-6/University.ht
    ml

23
Tests and monitoring in HIV infection
  • UK standard of care (BHIVA)
  • All patients should have
  • i) a resistance test at diagnosis,
  • ii) before starting HAART,
  • iii) if viral load does not drop by lt1log10
    after 4-8 weeks after starting HAART, (genotype)
  • iv) after virological failure

24
Tests and monitoring in HIV infection
  • UK standard of care
  • BHIVA viral load before and 4-8 weeks after
    starting treatment (as necessary thereafter)

25
Tests and monitoring in HIV infection
  • UK standard of care
  • BHIVA CD4 count before treatment (as necessary
    thereafter)

26
Tests and monitoring in HIV infection
  • UK standard of care
  • BHIVA TDM for management of drug interactions,
    pregnancy and paediatrics, highly
    treatment-experienced patients when TDM and
    resistance test results can be integrated, kidney
    or liver impairment, transplant patients, drug
    toxicity, alternative dosing where safety and
    efficacy has not been established

27
Tests and monitoring in HIV infection
  • UK standard of care and some other useful tests

28
Tests and monitoring in HIV infection
  • Liver enzymes
  • Kidney function
  • Urine
  • Albumin
  • Bone density
  • Glucose
  • Platelets
  • Red blood count
  • White blood count
  • Lipids

29
Tests and monitoring in HIV infection
  • C-reactive protein
  • DEXA scan
  • Chest x-ray
  • Sputum serology
  • Lactic acid and blood pH
  • Haemoglobin and iron
  • Serum urea
  • Creatine phosphokinase and lactate dehydrogenase
  • Electrolytes

30
Tests and monitoring in HIV infection
  • Tests blood, blood and more blood...
  • Many tests require a blood sample

31
Tests and monitoring in HIV infection
  • Blood glucose
  • Blood cholesterols and triglycerides
  • Kidney function
  • C-reactive protein
  • Liver enzymes
  • Anaemia
  • Lactic acidosis

32
Tests and monitoring in HIV infection
  • Blood glucose
  • Normal range 4-8 millimoles per litre (µmol/L)
  • High glucose ? kidney disease, neuropathy,
    insulin resistance, cardiovascular disease
  • Drugs PIs, tenofovir, AZT?

33
Tests and monitoring in HIV infection
  • Blood cholesterols and triglycerides
  • Low-density lipoproteins (LDLs) or "bad"
    cholesterol, and high-density lipoproteins (HDLs)
    or "good" cholesterol ratio is key measure
  • Insulin resistance, metabolic syndrome,
    cardiovascular disease
  • Drugs PIs, AZT, efavirenz

34
Tests and monitoring in HIV infection
  • Blood cholesterols and triglycerides
  • Total cholesterol
  • Target level under 5.2 µmol/L (4-6.4 µmol/L)

35
Tests and monitoring in HIV infection
  • Blood cholesterols and triglycerides
  • LDL cholesterol
  • Target level under 3.4 µmol/L

36
Tests and monitoring in HIV infection
  • Blood cholesterols and triglycerides
  • HDL cholesterol
  • Target level over 0.9 µmol/L

37
Tests and monitoring in HIV infection
  • Blood cholesterols and triglycerides
  • Cholesterol CV risk cannot be judged on
    cholesterol levels alone, HDLLDL ratio,
    lifestyle, BMI, age and other factors are
    important
  • Smoking!

38
Tests and monitoring in HIV infection
  • Blood cholesterols and triglycerides
  • Triglycerides
  • Fasted levels lt2.2 µmol/L normal, 2.24.4 µmol/l
    borderline, gt11 µmol/L very high
  • Each 1.1 µmol/L increased the risk of a heart
    attack by about 25 in men and 60 in women

39
Tests and monitoring in HIV infection
  • Urine
  • Dipstick test
  • Protein kidney (tenofovir) ltlt mostly albumin
  • Glucose insulin resistance (PIs), kidney
    (tenofovir, indinavir?, atazanavir?)
  • Bilirubin liver ( X atazanavir)
  • Sensitive but not specific

40
Tests and monitoring in HIV infection
  • Kidney function
  • Urine dipstick test or blood test first test
    and is indicative but inconclusive

41
Tests and monitoring in HIV infection
  • Kidney function
  • Serum creatinine (blood, not very specific or
    sensitive)
  • Creatinine clearance (blood and/or urine samples
    over 24 hours)
  • Calculated creatinine clearance (1 blood sample)
    also called estimated glomular filtration rate
    (eGFR)
  • Creatinine clearance can increase in pregnancy

42
Tests and monitoring in HIV infection
  • Kidney function
  • Different formulas to calculate GFR
  • http//en.wikipedia.org/wiki/Glomerular_filtration
    _rate

43
Tests and monitoring in HIV infection
  • C-reactive protein
  • Risk of diabetes, hypertension and CV disease
  • Low risk lt1mg/L
  • High risk gt3mg/L
  • Drugs PIs?, AZT?
  • C-reactive protein is a plasma protein produced
    by the liver (so, another blood test...)

44
Tests and monitoring in HIV infection
  • C-reactive protein
  • C-reactive protein is also marker of inflammation
    from infection but seems to be a reliable marker
    for CV disease in HIV regardless of HAART
  • http//gateway.nlm.nih.gov/MeetingAbstracts/102261
    383.html

45
Tests and monitoring in HIV infection
  • Liver enzymes
  • AST, ALT, ALP, GGT and bilirubin
  • Many conditions, some specific indications,
    complicated by hepatitis B and C coinfection,
    pharmacological agents (all kinds) and food
  • Drugs ritonavir, nevirapine, efavirenz,
    tipranavir, atazanavir, indinavir, d4T - most
    ARVS and many other drugs may affect the liver

46
Tests and monitoring in HIV infection
  • Liver enzymes
  • ALT (alanine aminotransferase)
  • Normal range 7-30 units/L W, 10-55 units/L M
  • May be more reliable sign of liver damage

47
Tests and monitoring in HIV infection
  • Liver enzymes
  • AST (aspartate aminotransferase)
  • Normal range 9-25 units/L W, 10-40 units/L M
  • Unreliable sign of liver damage
  • Pregnancy may decrease AST

48
Tests and monitoring in HIV infection
  • Liver enzymes
  • ALP (alkaline phosphatase)
  • Normal range 30-100 units/L W, 45-115 units/L M
  • Non-specific sign of liver damage
  • Atazanavir and indinavir can raise ALP

49
Tests and monitoring in HIV infection
  • Liver enzymes
  • GGT (gamma glutamyl transferase)
  • Normal range gt50 units/L W, gt65 units/L M
  • Can be specific sign of liver damage

50
Tests and monitoring in HIV infection
  • Liver enzymes
  • Interpretation requires experience and the whole
    picture
  • ALP GGT normal bone disease?
  • ALP GGT bile ducts? liver damage?
  • 10 x ALT/AST viral hepatitis? ARVs?

51
Tests and monitoring in HIV infection
  • Liver enzymes
  • Bilirubin
  • Direct (unconjugated) 0-7 µmol/L
  • Total 0-17 µmol/L
  • Bilirubin levels slightly higher in males than
    females, black Africans.
  • Drugs atazanavir, indinavir

52
Tests and monitoring in HIV infection
  • Liver enzymes
  • Bilirubin
  • Jaundice clinically detectable at levels above 40
    µmol/l.
  • Exception with atazanavir (or ritonavir) if
    bilirubin levels around 60-70 µmol/l

53
Tests and monitoring in HIV infection
  • Liver enzymes
  • Bilirubin jaundice
  • Other enzymes may show no outward sign

54
Tests and monitoring in HIV infection
  • Liver enzymes
  • Q what is the most liver-damaging
    over-the-counter (OTC) medicine?

55
Tests and monitoring in HIV infection
  • Liver enzymes
  • Q what is the most liver-damaging
    over-the-counter (OTC) medicine?
  • A Paracetamol

56
Tests and monitoring in HIV infection
  • Liver enzymes
  • WHO's top 10 liver-damaging medicines
  • Paracetamol, troglitazone, valproic acid, d4T,
    halothene, 3TC, ddI, amiodarone, nevirapine,
    cotrimoxazole
  • The ABCs of liver disease, Edwin J Bernard, NAM
  • http//www.aidsmap.com/files/file1000630.pdf

57
Tests and monitoring in HIV infection
  • Liver
  • PT time Prothrombin Time
  • Also called INR - International Normalized Ratio
  • Evaluate the ability of blood to clot properly
  • Not an enzyme test

58
Tests and monitoring in HIV infection
  • Liver
  • PT time Prothrombin Time
  • Monitor anti-coagulants?, bleeding disorders,
    before surgery
  • Normal range 11-13.5 seconds
  • 1.5-2 times normal too slow but no consensus on
    calibration of test as marker of over-fast
    clotting

59
Tests and monitoring in HIV infection
  • Liver
  • PT time Prothrombin Time
  • INR (Pt test / PT normal) ISI
  • ISI International Sensitivity Index for tissue
    factor (1-1.4)

60
Tests and monitoring in HIV infection
  • Anaemia
  • Iron, B12, B6, folic acid, red blood count,
    heamoglobin (HGB), mean corpuscular haemoglobin
    (MCH), heamocrit (HCT), mean corpuscular volume
    (MCV)
  • Drugs AZT (pregnant?)

61
Tests and monitoring in HIV infection
  • Anaemia
  • Haemocrit
  • Normal ranges 40-52 M 35-35 W
  • Low haematocrit anaemia?

62
Tests and monitoring in HIV infection
  • Anaemia
  • Haemoglobin
  • Normal ranges 11.5- to 16.5g W 13-18g M per 100mL
    blood
  • Low haemoglobin anaemia?

63
Tests and monitoring in HIV infection
  • Anaemia
  • Mean corpuscular volume
  • Larger anaemic, B6, B12, folic acid deficiency?
  • Smaller anaemic, iron deficiency?
  • AZT (and smoking) can increase MCV without
    causing anaemia

64
Tests and monitoring in HIV infection
  • Anaemia
  • Red blood count (total erythrocytes)
  • Normal range 3.8-5 W 4.5-6.5 M billion per litre
    or million per cubic millimitre of blood
    (1012/L).
  • Low count anaemia? but not sensitive or
    specific probably a first test

65
Tests and monitoring in HIV infection
  • The rest...
  • Blood chemistry
  • http//www.aidsmeds.com/articles/CSTest_4730.shtml
  • http//www.aidsmeds.com/articles/CBCTest_4729.shtm
    l
  • A-Z tests
  • http//www.aidsmap.com/cms1031936.asp
  • http//www.labtestsonline.org.uk/
  • Hepatitis C coinfection liver and diagnosis
  • http//www.i-base.info/guides/hepc/livertests.html
  • http//www.i-base.info/guides/hepc/hcvtesting.html

66
Tests and monitoring in HIV infection
  • Tests to avoid during pregnancy
  • Amniocentesis
  • Chorionic villus sampling
  • Fetal scalp sampling
  • Cordocentis
  • Percutaneous umbilical cord sampling
  • Internal fetal labour monitoring (external
    ultrasound and fetal monitoring OK)

67
Tests and monitoring in HIV infection
  • Plebotomy (having blood taken)
  • A cruel and unusual punishment - or nice chat
    with the nurse?

68
Tests and monitoring in HIV infection
  • Blood count reference ranges
  • Red blood count (RBC) 3.8 to 5 W 4.5-6.5 M
    million per mm3
  • White blood count (WBC) 4-11 per mm3
  • Haemoglobin (HGB, Hg) 11.5-16.5 W 13-18 M g per
    100mL
  • Neutropils 2-7.5 per mm3
  • Lymphocytes 1.3-4 per mm3
  • Platelets 150-440 per per mm3
  • Mean corpuscular volume (MCV) 80-97

69
Tests and monitoring in HIV infection
  • Blood count reference ranges
  • CD4 400-1,600 per mm3
  • CD4 32-68
  • CD8 140-1000 per mm3
  • CD4CD8 ratio 0.9-6

70
Tests and monitoring in HIV infection
  • Sampling
  • Biggest causes of odd results are sampling
    error, processing error or sample
    contamination
  • wrong tube, wrong person's sample,
    cross-contamination, sample too hot/cold/old,
    wrong reagent, wrongly set up equipment, not
    reading instructions, misreading output...

71
Tests and monitoring in HIV infection
  • Results
  • One result is rarely conclusive
  • ANY unusual or unexpected results should ALWAYS
    be retested before making a treatment decision
  • Normal is a difficult word tests refer to
    reference ranges, can mean doctor/nurse is happy
    with results even though high/low

72
Tests and monitoring in HIV infection
  • Sensitive v specific
  • Sensitivity reacts positively
  • Specificity reacts positively in right
    circumstances

73
Tests and monitoring in HIV infection
  • Sensitive v specific
  • Sensitivity rule in
  • Sensitivity refers to the proportion of people
    with disease who have a positive test result
  • Specificity rule out
  • Specificity refers to the proportion of people
    without disease who have a negative test result.

74
Tests and monitoring in HIV infection
  • Sensitive v specific
  • SnNout when a sign, test or symptom has a high
    Sensitivity, a Negative result rules out the
    diagnosis.
  • SpPin when a sign, test or symptom has a high
    Specificity, a Positive result rules in the
    diagnosis.

75
Tests and monitoring in HIV infection
  • Sensitive v specific
  • Many rapid tests are highly sensitive but not
    specific enough to be definitive prone to
    sample contamination
  • Urine dipstick tests
  • Fingerprick tests
Write a Comment
User Comments (0)
About PowerShow.com